David O. Morgan

35.0k total citations · 15 hit papers
190 papers, 27.3k citations indexed

About

David O. Morgan is a scholar working on Molecular Biology, Cell Biology and Oncology. According to data from OpenAlex, David O. Morgan has authored 190 papers receiving a total of 27.3k indexed citations (citations by other indexed papers that have themselves been cited), including 137 papers in Molecular Biology, 86 papers in Cell Biology and 37 papers in Oncology. Recurrent topics in David O. Morgan's work include Microtubule and mitosis dynamics (81 papers), Ubiquitin and proteasome pathways (37 papers) and Cancer-related Molecular Pathways (34 papers). David O. Morgan is often cited by papers focused on Microtubule and mitosis dynamics (81 papers), Ubiquitin and proteasome pathways (37 papers) and Cancer-related Molecular Pathways (34 papers). David O. Morgan collaborates with scholars based in United States, United Kingdom and Estonia. David O. Morgan's co-authors include Richard A. Roth, Robert P. Fisher, Jody Rosenblatt, Yong Gu, William J. Rutter, Sue L. Jaspersen, Yun Gu, Justin D. Blethrow, Jin Pei and Christoph W. Turck and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

David O. Morgan

185 papers receiving 26.6k citations

Hit Papers

Principles of CDK regulation 1986 2026 1999 2012 1995 1997 1986 1992 2000 500 1000 1.5k 2.0k 2.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David O. Morgan United States 74 21.1k 9.4k 8.4k 2.1k 1.8k 190 27.3k
Susan S. Taylor United States 98 29.1k 1.4× 5.6k 0.6× 3.5k 0.4× 1.3k 0.7× 2.0k 1.1× 462 35.7k
Peter J. Parker United Kingdom 95 25.3k 1.2× 7.6k 0.8× 3.9k 0.5× 820 0.4× 1.5k 0.8× 406 33.7k
Mark A. Lemmon United States 78 18.3k 0.9× 7.1k 0.8× 5.7k 0.7× 766 0.4× 1.3k 0.7× 159 25.5k
Thomas M. Roberts United States 84 19.6k 0.9× 3.6k 0.4× 7.6k 0.9× 1.4k 0.7× 3.4k 1.8× 309 28.9k
Alfred Wittinghofer Germany 96 25.9k 1.2× 8.3k 0.9× 3.1k 0.4× 1.1k 0.5× 2.7k 1.5× 296 31.2k
Michael B. Yaffe United States 90 23.8k 1.1× 7.9k 0.8× 5.7k 0.7× 1.2k 0.6× 1.5k 0.9× 279 30.9k
Marcos Malumbres Spain 64 14.8k 0.7× 5.0k 0.5× 8.0k 0.9× 718 0.3× 1.2k 0.7× 186 21.4k
David Barford United Kingdom 73 17.1k 0.8× 3.8k 0.4× 3.1k 0.4× 1.1k 0.5× 941 0.5× 158 20.4k
John Kuriyan United States 99 28.8k 1.4× 4.9k 0.5× 7.0k 0.8× 941 0.5× 3.1k 1.7× 235 38.8k
Anne‐Claude Gingras Canada 88 25.7k 1.2× 5.5k 0.6× 2.9k 0.3× 1.2k 0.6× 2.2k 1.2× 318 32.0k

Countries citing papers authored by David O. Morgan

Since Specialization
Citations

This map shows the geographic impact of David O. Morgan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David O. Morgan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David O. Morgan more than expected).

Fields of papers citing papers by David O. Morgan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David O. Morgan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David O. Morgan. The network helps show where David O. Morgan may publish in the future.

Co-authorship network of co-authors of David O. Morgan

This figure shows the co-authorship network connecting the top 25 collaborators of David O. Morgan. A scholar is included among the top collaborators of David O. Morgan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David O. Morgan. David O. Morgan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ghent, Chloe M., et al.. (2025). Substrate recognition by human separase. Science Advances. 11(46). eady9807–eady9807.
2.
Syed, Abdullah M., Alison Ciling, Irene P. Chen, et al.. (2024). SARS-CoV-2 evolution balances conflicting roles of N protein phosphorylation. PLoS Pathogens. 20(11). e1012741–e1012741. 6 indexed citations
3.
Ghent, Chloe M., Tobias Raisch, Yashar Sadian, et al.. (2021). Structural basis of human separase regulation by securin and CDK1–cyclin B1. Nature. 596(7870). 138–142. 59 indexed citations
4.
Morgan, David O.. (2021). : Religious Materiality in the Early Modern World. Renaissance Quarterly. 74(2). 648–650.
5.
Mizrak, Arda & David O. Morgan. (2019). Polyanions provide selective control of APC/C interactions with the activator subunit. Nature Communications. 10(1). 5807–5807. 9 indexed citations
6.
Rosen, Laura E., Joseph E. Klebba, Jonathan B Asfaha, et al.. (2019). Cohesin cleavage by separase is enhanced by a substrate motif distinct from the cleavage site. Nature Communications. 10(1). 5189–5189. 24 indexed citations
7.
Girard, Juliet R., et al.. (2015). An E2 Accessory Domain Increases Affinity for the Anaphase-promoting Complex and Ensures E2 Competition. Journal of Biological Chemistry. 290(40). 24614–24625. 7 indexed citations
8.
Lyons, Nicholas A. & David O. Morgan. (2011). Cdk1-Dependent Destruction of Eco1 Prevents Cohesion Establishment after S Phase. Molecular Cell. 42(3). 378–389. 66 indexed citations
9.
Holt, Liam J., Brian B. Tuch, Judit Villén, et al.. (2009). Global Analysis of Cdk1 Substrate Phosphorylation Sites Provides Insights into Evolution. Science. 325(5948). 1682–1686. 716 indexed citations breakdown →
10.
Benanti, Jennifer A., Mary E. Matyskiela, David O. Morgan, & David P. Toczyski. (2009). Functionally Distinct Isoforms of Cik1 Are Differentially Regulated by APC/C-Mediated Proteolysis. Molecular Cell. 33(5). 581–590. 26 indexed citations
11.
Morgan, David O.. (2008). SnapShot: Cell-Cycle Regulators I. Cell. 135(4). 764–764.e1. 10 indexed citations
12.
Sullivan, Matt & David O. Morgan. (2007). Finishing mitosis, one step at a time. Nature Reviews Molecular Cell Biology. 8(11). 894–903. 267 indexed citations
13.
Rodrigo-Brenni, Monica C. & David O. Morgan. (2007). Sequential E2s Drive Polyubiquitin Chain Assembly on APC Targets. Cell. 130(1). 127–139. 208 indexed citations
14.
Holt, Liam J., Jessica E. Hutti, Lewis C. Cantley, & David O. Morgan. (2007). Evolution of Ime2 Phosphorylation Sites on Cdk1 Substrates Provides a Mechanism to Limit the Effects of the Phosphatase Cdc14 in Meiosis. Molecular Cell. 25(5). 689–702. 60 indexed citations
15.
Skelton, Victoria, Gillian M. Greenway, Stephen J. Haswell, et al.. (2001). The generation of concentration gradients using electroosmotic flow in micro reactors allowing stereoselective chemical synthesis. The Analyst. 126(1). 11–13. 46 indexed citations
16.
Liu, Yi, Anthony C. Bishop, Laurie Witucki, et al.. (1999). Structural basis for selective inhibition of Src family kinases by PP1. Chemistry & Biology. 6(9). 671–678. 211 indexed citations
17.
Espinoza, F. Hernán, Alison Farrell, Jamison L. Nourse, et al.. (1998). Cak1 Is Required for Kin28 Phosphorylation and Activation In Vivo. Molecular and Cellular Biology. 18(11). 6365–6373. 65 indexed citations
18.
Murphy, Steven M., Mathias Bergman, & David O. Morgan. (1993). Suppression of c-Src Activity by C-Terminal Src Kinase Involves the c-Src SH2 and SH3 Domains: Analysis with Saccharomyces cerevisiae. Molecular and Cellular Biology. 13(9). 5290–5300. 26 indexed citations
19.
Morgan, David O.. (1992). Cell cycle control in normal and neoplastic cells. Current Opinion in Genetics & Development. 2(1). 33–37. 44 indexed citations
20.
Morgan, David O., Joshua M. Kaplan, J. Michael Bishop, & Harold Varmus. (1991). [53] Production of p60c-src by baculovirus expression and immunoaffinity purification. Methods in enzymology on CD-ROM/Methods in enzymology. 200. 645–660. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026